Corient Private Wealth
TNYA icon

Corient Private Wealth’s Tenaya Therapeutics TNYA Stock Holding History

Corient Private Wealth’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$99.9K Sell
144,300
-57,300
-28% -$42.3K ﹤0.01% 2691
2025
Q4 		$143K Buy
+201,600
New +$274K ﹤0.01% 2621
2023
Q2 		– Sell
-12,753
Closed -$36.3K – 2170
2023
Q1 		$36.3K Buy
+12,753
New +$35.8K ﹤0.01% 1959

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corient Private Wealth's TNYA Position: Q1 2026 in Review

Corient Private Wealth reduced its Tenaya Therapeutics (TNYA) stake by 28% in Q1 2026, selling an estimated $42.3K and leaving 144,300 shares worth $99.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2691.

Corient Private Wealth first reported a position in TNYA in Q1 2023 and has held it in 3 quarters since. The position peaked at $143K in Q4 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Corient Private Wealth held 144,300 shares of Tenaya Therapeutics worth $99.9K as of Q1 2026.
  • Corient Private Wealth sold 57,300 Tenaya Therapeutics shares in Q1 2026, an estimated $42.3K.
  • Tenaya Therapeutics made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2691 holding.
  • Corient Private Wealth first reported a position in Tenaya Therapeutics in Q1 2023 and has held it in 3 quarters since.
  • Corient Private Wealth's Tenaya Therapeutics position peaked at $143K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.